+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Combination Antibody Therapy"

Global Combination Antibody Therapy Market by Type (Antibody-Drug Conjugates, Bispecific Antibodies, Chemotherapy-Monoclonal Antibodies), Indication (Cancer, HIV), Route of Administration, Distribution Channel, End-Use - Forecast 2024-2030 - Product Thumbnail Image

Global Combination Antibody Therapy Market by Type (Antibody-Drug Conjugates, Bispecific Antibodies, Chemotherapy-Monoclonal Antibodies), Indication (Cancer, HIV), Route of Administration, Distribution Channel, End-Use - Forecast 2024-2030

  • Report
  • March 2024
  • 188 Pages
  • Global
From
Combination Antibody Therapy - Global Strategic Business Report - Product Thumbnail Image

Combination Antibody Therapy - Global Strategic Business Report

  • Report
  • May 2024
  • 196 Pages
  • Global
From
Combination Antibody Therapy Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region - Product Thumbnail Image

Combination Antibody Therapy Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region

  • Report
  • March 2024
  • 234 Pages
  • Global
Combination Antibody Therapy Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type - Product Thumbnail Image

Combination Antibody Therapy Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • June 2023
  • 90 Pages
  • Global
From
  • 4 Results (Page 1 of 1)
Loading Indicator

Combination Antibody Therapy is a type of oncology drug that combines two or more monoclonal antibodies to target cancer cells. This type of therapy is used to treat a variety of cancers, including breast, lung, and colorectal cancer. It works by blocking the growth of cancer cells and preventing them from spreading. The combination of antibodies can also help to reduce the side effects of chemotherapy and radiation therapy. Combination Antibody Therapy is becoming increasingly popular as a treatment for cancer due to its effectiveness and safety. It is also being used in combination with other treatments, such as immunotherapy, to improve outcomes. Some companies in the Combination Antibody Therapy market include Bristol-Myers Squibb, Merck, Roche, AstraZeneca, and Novartis. Show Less Read more